大学生结核病控制的研究:(二)结核感染者的预防性治疗

摘要/Abstract

摘要： 目的　探讨在大学生中开展结核感染的预防性治疗的效果,及其方案和管理措施。方法经广泛宣传后,学生红十字会员、校医院主管医生和结核病防治所分工管理,在知情同意基础上对PPD≥15mm新入学学生开展预防性治疗。将学生自然分为治疗组和对照组,两组均进行4年的发病观察。分别计算发病率。治疗方案每周2次口服利福喷汀加异烟肼,连续3个月,共服药25次。结果 1948名学生参预防性治疗,完成疗程率90%,不良反应率3.3%,因不良反应而停药率1.0%。4年中发生结核病5例,年均发病率64.17/10万。对照组共1765名4年中发生结核18例,年均发病率254.96/10万,预防性治疗减少发病的保护率为74.8%。结论在大学生中采用3个月每周2次口服利福喷汀加异烟肼方案预防性治疗有效、可行和安全。在进行预防性治疗时,需落实传染源控制和组织管理措施,并注意不良反应的观察。

关键词: 结核/预防和控制, 预防性治疗

Abstract: Objective To investigate efficacy of preventive chemotherapy treatment and management of administration for tuberculosis-infected students of university. Methods Members of Red Cross, doctors from hospital of university and district tuberculosis center were combined and shared out the work and help one another, including extensive health promotion PPD testing and management of preventive chemotherapy. Preventive chemotherapy was given to new students with over 15 mm PPD testing reactors based their consent. Placebo-controlled study was adopted and incidence rate was investigated during follow-up 4 years. Rifapentine and isoniazid intermittent regimen was selected twice weekly for 3 months, total 25 times. Results There were 3 713 students enrolled, 1948 and 1765 students of which were selected as treated and placebo groups respectively. Complete treatment rate was 90%. Side effects rate was 3.3% and stopping drug treatment rate 0.98%. There were 5 cases, 64.17/100,000 and 18 cases, 254.96/100,000 occurred in treated and placebo groups during 4 years follow-up respectively. It showed 74.8% protection against subsequent tuberculosis. Conclusion Previntive treatment with Rifapentine and Isoniazid twice weekly for 3 months is effectiveness, safety and feasibility in the students of university.

Key words: Tuberculosis/prevention and control, Preventive chemotherapy treatment.

刘玉清,屠德华,安燕生,张立兴,. 大学生结核病控制的研究:(二)结核感染者的预防性治疗[J]. 中国防痨杂志, 2005, 27(3): 139-142.

Liu Yuqing¹,Tu Dehua, An Yansheng,et al.. Control in university students in Beijing:preventive therapy for tuberculosis-infected persons[J]. Chinese Journal of Antituberculosis, 2005, 27(3): 139-142.

[1]	卢鹏,成君,路希维,刘二勇,周林,陆伟. 科学开展预防性治疗加速遏制结核病进程[J]. 中国防痨杂志, 2020, 42(4): 316-321.
[2]	任哲雯,成君,徐彩红,张慧. 肺结核患者密切接触者潜伏性结核感染预防性治疗研究进展[J]. 中国防痨杂志, 2019, 41(9): 1021-1024.
[3]	高磊,金奇. 关口前移:结核潜伏感染及其控制[J]. 中国防痨杂志, 2018, 40(8): 791-795.
[4]	方勇，肖和平. 潜伏性结核感染的诊治进展[J]. 中国防痨杂志, 2016, 38(2): 144-147.
[5]	肖和平. 立法管理结核病传染源刻不容缓[J]. 中国防痨杂志, 2015, 37(9): 921-922.
[6]	李涛，成诗明，杜昕. 全国结核病防治工作模式与患者发现和治疗管理水平分析[J]. 中国防痨杂志, 2015, 37(1): 30-34.
[7]	艾静文，阮巧玲，张文宏. 结核分枝杆菌潜伏感染预防性治疗的进展[J]. 中国防痨杂志, 2015, 37(1): 80-85.
[8]	姜世闻，刘小秋. 我国流动人口结核病防治工作的进展与展望[J]. 中国防痨杂志, 2014, 36(9): 798-801.
[9]	周林，刘二勇. 国内外Mtb与HIV双重感染防治进展与展望[J]. 中国防痨杂志, 2014, 36(9): 802-805.
[10]	钟球，尹建军，高翠南，张建辉，周琳. 我国结核病防治科普工作的回顾与展望[J]. 中国防痨杂志, 2014, 36(9): 806-809.
[11]	王黎霞，姜世闻. 我国结核病控制策略的发展与展望[J]. 中国防痨杂志, 2014, 36(8): 630-633.
[12]	成君，赵飞，胡冬梅，张灿有，樊海英，李萌，成诗明，王黎霞. 构建结核病实施性研究课题评价指标体系的研究[J]. 中国防痨杂志, 2014, 36(5): 313-317.
[13]	赵飞，王黎霞，何广学，成诗明，张慧，屈燕，黄飞，胡冬梅，张灿有，樊海英，李萌，成君. 三个地区结核病定点医疗机构结核分枝杆菌感染控制现状调查分析[J]. 中国防痨杂志, 2014, 36(5): 318-322.
[14]	康万里，凌颖，徐苗，赵爱华，都伟欣，陈鸣，高铁杰，张治国，胡代玉，冯先惠，郭菁，张海霞，何菊，刘冠，李海英，吴新悦，王翠芝，郑素华，王国治. 皮内注射卡介苗接种效果的评价[J]. 中国防痨杂志, 2014, 36(4): 248-252.
[15]	王吉春，路凯，赵飞，陈亮，王敏，张莹，秦宇，焦怡琳，宋渝丹，耿梦杰，赵雁林，何广学. 一种上层空间紫外线杀菌系统的照射效能评价[J]. 中国防痨杂志, 2014, 36(4): 253-255.

大学生结核病控制的研究:(二)结核感染者的预防性治疗

Control in university students in Beijing:preventive therapy for tuberculosis-infected persons

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

友情链接